 REDWOOD CITY, Calif., Feb. 08, 2022 GLOBE NEWSWIRE -- Soleno Therapeutics, Inc. Soleno NASDAQ: SLNO, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present a corporate overview at the BIO CEO Investor Conference on Tuesday, February 15, 2022 at 2:15 PM Eastern Time. 